Shionogi, JP3347200002

Shionogi stock shifts focus to its Actair transfer

Published on 10/08/2026 at 08:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Shionogi stock was at JPY 2,765 on October 8, 2026, while Q1 fiscal 2027 revenue reached JPY 163.31 billion. Analysts see a JPY 3,358.3 average target.

Shionogi, JP3347200002, Illustration mit AI erstellt.
Shionogi, JP3347200002, Illustration mit AI erstellt.

Shionogi stock (ISIN JP3347200002) was trading at JPY 2,765 on the Tokyo Stock Exchange on October 8, 2026, at 2:46 p.m. JST, up 0.09 percent from the prior close. The company had agreed on October 6, 2026, to transfer Actair marketing authorization and sales operations in Japan, according to Shionogi.

Actair transfer sets a clear date

Actair marketing authorization is scheduled to move from Shionogi to CEOLIA in December 2026, followed by the transfer of sales operations in February 2027, according to the October 6 announcement. The agreement concerns an allergen immunotherapy treatment for house dust mite allergy in Japan.

The move narrows Shionogi's direct operating role for Actair while keeping the two companies involved in continued supply. For the stock, the event is more relevant as a portfolio and operating-efficiency update than as a quantified earnings catalyst.

Q1 revenue rose 63.7 percent

Shionogi's first-quarter fiscal 2027 revenue reached JPY 163.31 billion for the period ended June 30, 2026, up 63.7 percent from the year-earlier quarter, according to Investor Trader. The same report put profit attributable to owners at JPY 97.7 billion, up 148.2 percent year over year.

Those figures reflect the contribution of acquired and transferred businesses, including the edarabone business and other pharmaceutical assets. The comparison therefore describes a larger reporting base as well as operating growth, an important distinction when investors assess the next quarter.

Analysts see room above JPY 2,765

The consensus rating is Buy, based on 12 analysts, with 5 Buy ratings, 7 Holds and 0 Sells, according to Investing.com. The average 12-month target is JPY 3,358.3, with a high of JPY 4,000 and a low of JPY 2,900.

Against the JPY 2,765 Tokyo price, the average target lies 21.5 percent above the stock. The current quote sits inside a 52-week range of JPY 2,392.50 to JPY 3,758, leaving the Actair transition and the durability of acquisition-led growth as the next operating checkpoints.

Shionogi stock stays near JPY 2,765

Shionogi stock was last at JPY 2,765 on the Tokyo Stock Exchange on October 8, 2026, at 2:46 p.m. JST, with market capitalization of JPY 2.4 trillion.

Shionogi stock facts

  • Company: Shionogi & Co., Ltd.
  • ISIN: JP3347200002
  • Ticker: 4507
  • Trading venue: Tokyo Stock Exchange
  • Price (as of October 8, 2026, 2:46 p.m. JST): JPY 2,765
  • Market capitalization: JPY 2.4 trillion (as of October 8, 2026)
  • 52-week range: JPY 2,392.50-3,758
  • Sector / Industry: Health Care

More news and analyses on Shionogi stock

Disclaimer...

en | JP3347200002 | SHIONOGI | boerse | 70261962 | bgmi